Researchers develop injectable glucose-responsive micelles to treat hypoglycemia in diabetic patients.

Researchers have created an injectable solution using glucose-responsive micelles to prevent and treat hypoglycemia in diabetic patients. These micelles encapsulate glucagon, which is released only when blood sugar levels fall dangerously low. In mouse trials, the treatment restored normal glucose levels within 40 minutes. While further studies are needed, this development shows promise for an on-demand method to manage severe low blood sugar effectively.